Skip to Main Content (Press Enter)

Logo UNISR
  • ×
  • Home
  • People
  • Outputs
  • Organizations
  • Expertise & Skills

UNIFIND
Logo UNISR

|

UNIFIND

unisr.it
  • ×
  • Home
  • People
  • Outputs
  • Organizations
  • Expertise & Skills
  1. Outputs

First Italian consensus statement on diagnosis, prevention and treatment of cardiovascular complications in HIV-infected patients in the HAART era (2006)

Academic Article
Publication Date:
2007
Short description:
First Italian consensus statement on diagnosis, prevention and treatment of cardiovascular complications in HIV-infected patients in the HAART era (2006) / Carosi, G., Quiros roldan, E., Torti, C., Antinori, A., Bevilacqua, M., Bonadonna, R.C., Bonfanti, P., Castagna, A., Cauda, R., D'arminio monforte, A., Di Gregorio, P., Di Perri, G., Esposito, R., Fatuzzo, F., Gervasoni, C., Giannattasio, C., Guaraldi, G., Lazzarin, A., Lo Caputo, S., Maggi, P., et al.. - In: INFECTION. - ISSN 0300-8126. - 35:3(2007), pp. 134-142. [10.1007/s15010-007-6295-5]
abstract:
The present document contains recommendations for assessment, prevention and treatment of cardiovascular risk for HIV-infected patients. All recommendations were graded according to the strength and quality of the evidence and were voted on by 73 members of the Italian Cardiovascular Risk Guidelines Working Group which includes both experts in HIV/AIDS care and in cardiovascular and metabolic medicine. Since antiretroviral drug exposure represents only one risk factor, continued emphasis on an integrated management is given. This should include prevention and treatment of known cardiovascular risk factors (such as dyslipidaemia, diabetes, insulin resistance, healthy diet, physical activity, avoidance of smoking), but also rational switch of antiretroviral drugs. A rational switch strategy should consider both metabolic and anthropometric disturbances and effectiveness of antiretroviral regimens. © 2007 Urban & Vogel.
Iris type:
1.1 Articolo in rivista
Keywords:
Antiretroviral Therapy, Highly Active; Biomarkers; Cardiovascular Diseases; Diabetes Complications; Drug Interactions; Dyslipidemias; Female; HIV Infections; Humans; Insulin Resistance; Italy; Male; Risk Factors; Microbiology (medical); Infectious Diseases
List of contributors:
Carosi, G.; Quiros roldan, E.; Torti, C.; Antinori, A.; Bevilacqua, M.; Bonadonna, R. C.; Bonfanti, P.; Castagna, Antonella; Cauda, R.; D'arminio monforte, A.; Di Gregorio, P.; Di Perri, G.; Esposito, R.; Fatuzzo, F.; Gervasoni, C.; Giannattasio, C.; Guaraldi, G.; Lazzarin, Adriano; Lo Caputo, S.; Maggi, P.; Mazzotta, F.; Moroni, M.; Prestileo, T.; Ranieri, R.; Rizzardini, G.; Russo, R.; Galli, M.
Authors of the University:
CASTAGNA ANTONELLA
LAZZARIN ADRIANO
Handle:
https://iris.unisr.it/handle/20.500.11768/67427
Published in:
INFECTION
Journal
  • Use of cookies

Powered by VIVO | Designed by Cineca | 26.9.0.0